138 related articles for article (PubMed ID: 16570910)
1. Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures.
Feng BY; Shoichet BK
J Med Chem; 2006 Apr; 49(7):2151-4. PubMed ID: 16570910
[TBL] [Abstract][Full Text] [Related]
2. A high-throughput screen for aggregation-based inhibition in a large compound library.
Feng BY; Simeonov A; Jadhav A; Babaoglu K; Inglese J; Shoichet BK; Austin CP
J Med Chem; 2007 May; 50(10):2385-90. PubMed ID: 17447748
[TBL] [Abstract][Full Text] [Related]
3. Screening in a spirit haunted world.
Shoichet BK
Drug Discov Today; 2006 Jul; 11(13-14):607-15. PubMed ID: 16793529
[TBL] [Abstract][Full Text] [Related]
4. A specific mechanism of nonspecific inhibition.
McGovern SL; Helfand BT; Feng B; Shoichet BK
J Med Chem; 2003 Sep; 46(20):4265-72. PubMed ID: 13678405
[TBL] [Abstract][Full Text] [Related]
5. Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Seidler J; McGovern SL; Doman TN; Shoichet BK
J Med Chem; 2003 Oct; 46(21):4477-86. PubMed ID: 14521410
[TBL] [Abstract][Full Text] [Related]
6. Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods.
Houghten RA; Pinilla C; Giulianotti MA; Appel JR; Dooley CT; Nefzi A; Ostresh JM; Yu Y; Maggiora GM; Medina-Franco JL; Brunner D; Schneider J
J Comb Chem; 2008; 10(1):3-19. PubMed ID: 18067268
[No Abstract] [Full Text] [Related]
7. Kinase inhibitors: not just for kinases anymore.
McGovern SL; Shoichet BK
J Med Chem; 2003 Apr; 46(8):1478-83. PubMed ID: 12672248
[TBL] [Abstract][Full Text] [Related]
8. Promiscuous aggregate-based inhibitors promote enzyme unfolding.
Coan KE; Maltby DA; Burlingame AL; Shoichet BK
J Med Chem; 2009 Apr; 52(7):2067-75. PubMed ID: 19281222
[TBL] [Abstract][Full Text] [Related]
9. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
McGovern SL; Caselli E; Grigorieff N; Shoichet BK
J Med Chem; 2002 Apr; 45(8):1712-22. PubMed ID: 11931626
[TBL] [Abstract][Full Text] [Related]
10. Significant contributions of ionic liquids containing tetrafluoroborate and trifluoromethanesulfonate to antagonisms and synergisms in multi-component mixtures.
Zhang J; Liu SS; Yu ZY; Liu HL
J Hazard Mater; 2012 Mar; 209-210():158-63. PubMed ID: 22277336
[TBL] [Abstract][Full Text] [Related]
11. Synergism and antagonism.
Eliopoulos GM
Infect Dis Clin North Am; 1989 Sep; 3(3):399-406. PubMed ID: 2671129
[TBL] [Abstract][Full Text] [Related]
12. Effect of detergent on "promiscuous" inhibitors.
Ryan AJ; Gray NM; Lowe PN; Chung CW
J Med Chem; 2003 Jul; 46(16):3448-51. PubMed ID: 12877581
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams.
Heinze-Krauss I; Angehrn P; Charnas RL; Gubernator K; Gutknecht EM; Hubschwerlen C; Kania M; Oefner C; Page MG; Sogabe S; Specklin JL; Winkler F
J Med Chem; 1998 Oct; 41(21):3961-71. PubMed ID: 9767633
[TBL] [Abstract][Full Text] [Related]
14. Use of novel boronic acid transition state inhibitors to probe substrate affinity in SHV-type extended-spectrum beta-lactamases.
Thomson JM; Prati F; Bethel CR; Bonomo RA
Antimicrob Agents Chemother; 2007 Apr; 51(4):1577-9. PubMed ID: 17220410
[TBL] [Abstract][Full Text] [Related]
15. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
16. The applications of binuclear metallohydrolases in medicine: recent advances in the design and development of novel drug leads for purple acid phosphatases, metallo-β-lactamases and arginases.
McGeary RP; Schenk G; Guddat LW
Eur J Med Chem; 2014 Apr; 76():132-44. PubMed ID: 24583353
[TBL] [Abstract][Full Text] [Related]
17. A detergent-based assay for the detection of promiscuous inhibitors.
Feng BY; Shoichet BK
Nat Protoc; 2006; 1(2):550-3. PubMed ID: 17191086
[TBL] [Abstract][Full Text] [Related]
18. [Methodology of the hygienic evaluation of mixtures of hazardous substances].
Shtabskiĭ BM; Fedorenko VI
Gig Sanit; 1987 Sep; (9):60-3. PubMed ID: 3678874
[No Abstract] [Full Text] [Related]
19. Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins.
Hubschwerlen C; Angehrn P; Gubernator K; Page MG; Specklin JL
J Med Chem; 1998 Oct; 41(21):3972-5. PubMed ID: 9767634
[TBL] [Abstract][Full Text] [Related]
20. Understanding the longevity of the beta-lactam antibiotics and of antibiotic/beta-lactamase inhibitor combinations.
Buynak JD
Biochem Pharmacol; 2006 Mar; 71(7):930-40. PubMed ID: 16359643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
